Overview
BMNR market data
Price History
BMNR price chart
Valuation & Profitability
- P/E (TTM)
- 31.65 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $14.22 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.84 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.1% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -14,306.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $12.80 – $71.74 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11B · P/B 0.87 · P/S 180.30.
Company News
Bitcoin Slides; Ethereum, XRP, Dogecoin Gain Amid Softer PPI Inflation: Crypto 'Dead' Chatter Shows Retail Patience 'Breaking,' Says Market Intelligence FirmBenzinga · Aug 14, 2026, 2:00 AM
Ethereum Sentiment Turns Positive but Beware a Final Leg Lower, Analysts WarnBenzinga · Aug 13, 2026, 1:50 PM
Bitcoin, Ethereum, XRP, Dogecoin Slide Even as CPI Figures Ease Rate Hike Odds: Analyst Says BTC 'Displaying a Condition' Associated With Market BottomsBenzinga · Aug 13, 2026, 2:12 AM
Tom Lee's BitMine Is Close to Owning 5% of All ETH: What Happens to BMNR When It Does?Benzinga · Aug 12, 2026, 1:23 PM
Bitcoin Dips, Ethereum, XRP, Dogecoin Rise: Analyst Predicts 'BTC Goes Up' if Consumer Inflation Comes in Better Than ExpectedBenzinga · Aug 12, 2026, 1:57 AM
Bitcoin, Ethereum, XRP Dip, but Dogecoin Gains as US-Iran Tensions Persist: Analyst Says 'Next Sell-Off Soon' as Risk 'Predominates' on BTC ChartBenzinga · Aug 11, 2026, 2:00 AM
BMNR stock has given up its prior gain. BioMarin Pharmaceutical shares were trading higher after Canaccord Genuity maintained its Buy rating on the stock and raised its price target from $111 to $114.Benzinga · Aug 10, 2026, 6:17 PM
CORRECTION: BioMarin Pharmaceutical Ticker Is "BMRN"Benzinga · Aug 10, 2026, 5:51 PM
BioMarin Pharmaceutical shares are trading higher after Canaccord Genuity maintained its Buy rating on the stock and raised its price target from $111 to $114.Benzinga · Aug 10, 2026, 5:47 PM
Bitmine Buys 7,391 ETH for $14.3 Million, BMNR Down 2%: What's Going On?Benzinga · Aug 10, 2026, 2:27 PM